Harvey D. Preisler

6.9k total citations
229 papers, 5.5k citations indexed

About

Harvey D. Preisler is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Harvey D. Preisler has authored 229 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Hematology, 87 papers in Molecular Biology and 63 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Harvey D. Preisler's work include Acute Myeloid Leukemia Research (123 papers), Acute Lymphoblastic Leukemia research (61 papers) and Hematopoietic Stem Cell Transplantation (39 papers). Harvey D. Preisler is often cited by papers focused on Acute Myeloid Leukemia Research (123 papers), Acute Lymphoblastic Leukemia research (61 papers) and Hematopoietic Stem Cell Transplantation (39 papers). Harvey D. Preisler collaborates with scholars based in United States, Canada and Italy. Harvey D. Preisler's co-authors include Azra Raza, Gary H. Lyman, Youcef M. Rustum, Edward S. Henderson, William Scher, Charlotte Friend, Demetrios Papahadjopoulos, Amy Early, Maurice Barcos and George P. Browman and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Harvey D. Preisler

227 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harvey D. Preisler United States 37 2.5k 2.1k 1.7k 1.2k 974 229 5.5k
Bayard D. Clarkson United States 51 3.1k 1.2× 3.3k 1.5× 2.3k 1.4× 1.4k 1.2× 1.8k 1.9× 156 9.4k
R Powles United Kingdom 41 4.1k 1.6× 1.4k 0.6× 2.2k 1.3× 949 0.8× 779 0.8× 194 6.2k
E. Thiel Germany 46 2.1k 0.8× 1.4k 0.6× 1.7k 1.0× 1.7k 1.4× 1.4k 1.4× 208 6.9k
O. Ross McIntyre United States 30 2.0k 0.8× 1.1k 0.5× 865 0.5× 752 0.6× 579 0.6× 84 3.6k
Barthel Barlogie United States 44 2.0k 0.8× 2.5k 1.2× 2.2k 1.3× 525 0.4× 864 0.9× 121 7.0k
Bruno Rotoli Italy 42 2.3k 0.9× 949 0.4× 1.2k 0.7× 582 0.5× 1.1k 1.2× 185 5.5k
Sanford A. Stass United States 44 2.3k 0.9× 3.7k 1.7× 1.8k 1.1× 1.4k 1.2× 828 0.9× 143 7.5k
William C. Moloney United States 36 1.4k 0.6× 776 0.4× 1.0k 0.6× 633 0.5× 1.2k 1.2× 132 4.8k
François Dreyfus France 42 4.0k 1.6× 3.0k 1.4× 1.0k 0.6× 503 0.4× 1.6k 1.6× 126 6.2k
Beverly S. Mitchell United States 46 1.0k 0.4× 3.6k 1.7× 1.2k 0.7× 890 0.7× 715 0.7× 125 5.7k

Countries citing papers authored by Harvey D. Preisler

Since Specialization
Citations

This map shows the geographic impact of Harvey D. Preisler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey D. Preisler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey D. Preisler more than expected).

Fields of papers citing papers by Harvey D. Preisler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey D. Preisler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey D. Preisler. The network helps show where Harvey D. Preisler may publish in the future.

Co-authorship network of co-authors of Harvey D. Preisler

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey D. Preisler. A scholar is included among the top collaborators of Harvey D. Preisler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey D. Preisler. Harvey D. Preisler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coon, John S., Elizabeth A. Marcus, Shalina Gupta-Burt, et al.. (2002). Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer.. PubMed. 8(4). 1061–7. 145 indexed citations
2.
Galili, Uri, et al.. (2001). Preparation of Autologous Leukemia and Lymphoma Vaccines Expressing α -Gal Epitopes. Journal of Hematotherapy & Stem Cell Research. 10(4). 501–511. 14 indexed citations
3.
Preisler, Harvey D., Parameswaran Venugopal, S. A. Gregory, et al.. (2000). Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leukemia Research. 24(8). 671–680. 7 indexed citations
4.
Preisler, Harvey D.. (1998). Cytotoxic and Genotoxic Effects of Paclitaxel (Taxol®) and Radiation in a Squamous Cell Carcinoma Cell Line of the Larynx. Acta Oto-Laryngologica. 118(4). 600–605. 5 indexed citations
5.
Preisler, Harvey D., Suneel Mundle, John S. Coon, et al.. (1996). Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.. PubMed. 2(9). 1453–60. 11 indexed citations
6.
Raza, Azra, Harvey D. Preisler, George P. Browman, et al.. (1993). Long Term Outcome of Patients with Acute Myelogenous Leukemia: The Role of Maintenance Therapy, Consolidation Therapy and the Predictive Value of Twoin vitroAssays. Leukemia & lymphoma. 10(1-2). 57–66. 2 indexed citations
7.
Browman, George P. & Harvey D. Preisler. (1992). Predicting remission outcome in acute non-lymphocytic leukemia: General principles and their application to residual marrow leukemia. Leukemia Research. 16(5). 511–519. 5 indexed citations
8.
Larson, Richard A., Roger Day, N. Azarnia, et al.. (1992). The selective use of AMSA following high‐dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study. British Journal of Haematology. 82(2). 337–346. 13 indexed citations
9.
Silvestri, F, Shripad Banavali, Ben C. Hulette, et al.. (1992). CD34 antigen expression of acute myeloid leukemia-colony forming cells. Stem Cells. 10(S1). 98–100. 4 indexed citations
10.
Raza, Abbas, Mary Ann Miller, Claire Mazewski, et al.. (1991). Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine. Cell Proliferation. 24(2). 113–126. 13 indexed citations
11.
Raza, Azra, et al.. (1989). Detection of BrdU in the regenerating bone marrow cells of a patient with AML. Leukemia Research. 13(12). 1055–1059. 3 indexed citations
12.
Raza, Azra, et al.. (1987). Proliferative Characteristics of Acute Nonlymphocytic Leukemia in vivo. Acta Haematologica. 77(3). 140–145. 8 indexed citations
13.
Barcos, Maurice, Warren W. Lane, Germán A. Gómez, et al.. (1987). An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer. 60(4). 827–837. 184 indexed citations
14.
Preisler, Harvey D.. (1980). Evaluation of in vitro predictive assays for acute myelocytic leukemia. Annals of Hematology. 41(5). 393–396. 19 indexed citations
15.
Ho, Yau‐Kwan, Harvey D. Preisler, & Thomas J. Bardos. (1979). Effects of partially thiolated polycytidylic acid on the clonogenicity of murine leukemic stem cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(8). 3163–6. 6 indexed citations
16.
Preisler, Harvey D., et al.. (1979). Growth of human acute myeloblastic leukemic (AML) cells in vitro. Annals of Hematology. 38(1). 35–45. 3 indexed citations
17.
Preisler, Harvey D. & D. Shoham. (1978). Comparison of tritiated thymidine labeling and suicide indices in acute nonlymphocytic leukemia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 1). 3681–4. 26 indexed citations
18.
Lyman, Gary H., Demetrios Papahadjopoulos, & Harvey D. Preisler. (1976). Phospholipid membrane stabilization by dimethylsulfoxide and other inducers of friend leukemic cell differentiation. Biochimica et Biophysica Acta (BBA) - Biomembranes. 448(3). 460–473. 63 indexed citations
19.
Preisler, Harvey D. & Esmail D. Zanjani. (1974). Erythropoietin-induced stimulation of heme synthesis by dimethylsulfoxide-treated Friend leukemic cells in vitro.. PubMed. 84(5). 667–72. 3 indexed citations
20.
Friend, Charlotte, Harvey D. Preisler, & William Scher. (1974). Chapter 3 Studies on The Control of Differentiation of Murine Virus-Induced Erythroleukemic Cells. Current topics in developmental biology. 81–101. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bayard D. Clarkson Breakdown of academic impact, for papers by R Powles Breakdown of academic impact, for papers by E. Thiel Breakdown of academic impact, for papers by O. Ross McIntyre Breakdown of academic impact, for papers by Barthel Barlogie Breakdown of academic impact, for papers by Bruno Rotoli Breakdown of academic impact, for papers by Sanford A. Stass Breakdown of academic impact, for papers by William C. Moloney Breakdown of academic impact, for papers by François Dreyfus Breakdown of academic impact, for papers by Beverly S. Mitchell
Rankless by CCL
2026